Cryoablation comparable to surgery for treating early-stage kidney cancer
A study published in the journal Radiology from John Hopkins [...]
Immune-related adverse events and clinical outcome in kidney cancer treated with nivolumab
In a paper published in Clinical Genitourinary Cancer the link [...]
Clinical impact of COVID-19 on people with cancer
A recent publication in The Lancet looked at the effect [...]
COVID-19 outcomes in patient with cancer on anti-cancer treatments
Back in March at the start of the COVID-19 pandemic [...]
ASCO 2020: Lenvatinib plus pembrolizumab for disease progression after immunotherapy for metastatic kidney cancer
Results from a phase II trial of a combination of [...]
ASCO 2020: Subtypes of kidney cancer differ in sites of metastases
A paper presented during the 2020 American Society of Clinical [...]
Bone metastases are associated with poor prognosis in papillary kidney cancer
A recent retrospective study looked at the data from 49 [...]
Safety and efficacy of immunotherapy rechallenge in patients with kidney cancer
There are a number of immune checkpoint inhibitor drugs available [...]
How immunotherapy can treat advanced kidney cancer
This article gives a good, easy-to-understand summary of how the [...]
ASCO 2020: Nivolumab plus ipilimumab combination for previously treated kidney cancer
Results from the phase II FRACTION-RCC clinical trial to assess [...]
